Business Segment (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Schedule of operations by business segment

	Three Months Ended September 30,										Nine Months Ended September 30,
	Revenue				Earnings						Revenue				Earnings
	2022		2021		2022			2021			2022		2021		2022			2021
FOXO Labs	$	7	$	23	$	(499	)	$	(1,632	)	$	71	$	67	$	(1,952	)	$	(4,268	)
FOXO Life		7		8		(1,157	)		(831	)		22		26		(3,070	)		(1,667	)
		14		31		(1,656	)		(2,463	)		93		93		(5,022	)		(5,935	)
Corporate and other (a)						(38,946	)		(24,465	)						(70,660	)		(30,854	)
Interest expense						(424	)		(313	)						(1,250	)		(825	)
Total	$	14	$	31	$	(41,026	)	$	(27,241	)	$	93	$	93	$	(76,932	)	$	(37,614	)

(a) Corporate and other includes equity-based compensation, including the consulting agreement and Cantor Commitment Fee, expense of $3,866 and $42 as well as depreciation expense of $74 and $25 for the three months ended September 30, 2022 and 2021, respectively. Corporate and other includes equity-based compensation, including the consulting agreement and Cantor Commitment Fee, expense of $5,556 and $8 as well as depreciation expense of $159 and $71 for the nine months ended September 30, 2022 and 2021, respectively. The three months ended September 30, 2022 and 2021 included $31,010 and $22,571 for the changes in fair value of convertible debentures, warrant liability, and forward purchase derivatives. The nine months ended September 30, 2022 and 2021 also included $55,493 and $24,890 for the changes in fair value of convertible debentures, warrant liability, and forward purchase derivatives. See Notes 5, 6, 7, 9 and 11 for additional information.